Premium
Inherited intragenic PBX1 deletion: Expanding the phenotype
Author(s) -
Fitzgerald Kristi K.,
PowellHamilton Nina,
Shillingford Amanda J.,
Robinson Bradley,
Gripp Karen W.
Publication year - 2021
Publication title -
american journal of medical genetics part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.064
H-Index - 112
eISSN - 1552-4833
pISSN - 1552-4825
DOI - 10.1002/ajmg.a.61932
Subject(s) - haploinsufficiency , homeobox , biology , phenotype , genetics , transcription factor , tbx1 , branchial arch , gene , embryo , gene expression , promoter
PBX1 encodes the pre‐B cell leukemia homeobox transcription factor, a three amino acid loop extension (TALE) homeodomain transcription factor, which forms nuclear complexes with other TALE class homeodomain proteins that ultimately regulate target genes controlling organ patterning during embryogenesis. Heterozygous de novo pathogenic variants in PBX1 resulting in haploinsufficiency are associated with congenital anomalies of the kidneys and urinary tract, most commonly renal hypoplasia, as well as anomalies involving the external ear, branchial arch, heart, and genitalia, and they cause intellectual disability and developmental delay. Affected individuals described thus far have had de novo variants. Here, we report three related individuals with an inherited pathogenic intragenic PBX1 deletion with variable clinical features typical for this syndrome.